目的 研究肥胖儿童血清microRNA-122（miR-122）与胰岛素抵抗的关系。方法 选取47例7~14岁重度肥胖儿童为肥胖组，另选取与肥胖组性别及年龄匹配的正常体重健康儿童45例作为健康对照组，分别检测并记录两组儿童的身高、体重、腰围、臀围、空腹血糖（FBG）、空腹胰岛素（FINS）、甘油三酯（TG）、总胆固醇（TC）、游离脂肪酸（FFA）、白介素-6（IL-6）、miR-122水平，计算体重指数（BMI）、腰臀比（WHR）、胰岛素抵抗指数（HOMA-IR），并进行统计分析。结果 与健康对照组相比，肥胖组儿童身高、体重、BMI、WHR及FINS、HOMA-IR、TG、FFA、IL-6、miR-122水平均升高（P < 0.05）；肥胖组miR-122水平与FINS、HOMA-IR、IL-6水平呈正相关（分别r=0.408、0.442、0.464，P < 0.05）；miR-122的变化与IL-6有线性回归关系，且呈正相关（b'=0.318，P < 0.05）。结论 肥胖儿童血清miR-122可能与胰岛素抵抗相关，具体机制尚需进一步研究。
Abstract
Objective To study the relationship between serum microRNA-122 (miR-122) and insulin resistance in obese children. Methods Forty-seven children with severely obesity aged 7-14 years and 45 age-and gender matched healthy children with normal weight (control group) were enrolled. The levels of height, weight, waistline, hip circumference, fasting blood glucose (FBG), fasting insulin (FINS), triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), interleukin-6 (IL-6) and miR-122 in the two groups were measured. Body mass index (BMI), waist-hip ratio (WHR) and insulin resistance index (HOMA-IR) were calculated. Results Compared with the control group, the height, weight, BMI, WHR, FINS, HOMA-IR, TG, FFA, IL-6, and miR-122 levels in the obese group were significantly increased (P < 0.05). MiR-122 levels in the obese group were positively correlated with FINS, HOMA-IR and IL-6 levels (r=0.408, 0.442, and 0.464 respectively, P < 0.05). The changes of miR-122 have a linear regression relationship with IL-6 (b'=0.318, P < 0.05). Conclusions The elevated serum miR-122 levels may be correlated with insulin resistance in obese children. The mechanism needs to be further studied.
关键词
肥胖 /
microRNA-122 /
胰岛素抵抗 /
儿童
Key words
Obesity /
microRNA-122 /
Insulin resistance /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Liu JM, Ye R, Li S, et al. Prevalence of overweight/obesity in Chinese children[J]. Arch Med Res, 2007, 38(8):882-886.
[2] Willeit P, Skroblin P, Moschen AR, et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes[J]. Diabetes, 2017, 66(2):347-357.
[3] Wang R, Hong J, Cao Y, et al. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults[J]. Eur J Endocrinol, 2015, 172(3):291-300.
[4] Shah R, Murthy V, Pacold M, et al. Extracellular RNAs are associated with insulin resistance and metabolic phenotypes[J]. Diabetes Care, 2017, 40(4):546-553.
[5] Ortega FJ, Mercader JM, Catalán V, et al. Targeting the circulating microRNA signature of obesity[J]. Clin Chem, 2013, 59(5):781-792.
[6] 谷亚楠. 单纯性肥胖儿童胰岛素抵抗与IL-6、TNF-α、hs-CRP的关系[D]. 大连:大连医科大学, 2017.
[7] Nakamura M, Kanda T, Sasaki R, et al. MicroRNA-122 inhibits the production of inflammatory cytokines by targeting the PKR activator PACT in Human Hepatic Stellate Cells[J]. PLoS One, 2015, 10(12):e0144295.
[8] 中华儿科杂志编辑委员会, 中华医学会儿科学分会儿童保健学组. 儿童期单纯性肥胖症防治常规[J]. 中华儿科杂志, 2000, 38(9):568-570.
[9] Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents:a population-based study[J]. Diabetes Care, 2006, 29(11):2427-2432.
[10] Iliopoulos D, Drosatos K, Hiyama Y, et al. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism[J]. J Lipid Res, 2010, 51(6):1513-1523.
[11] Wu GY, Rui C, Chen JQ, et al. MicroRNA-122 inhibits lipid droplet formation and hepatic triglyceride accumulation via Yin Yang 1[J]. Cell Physiol Biochem, 2017, 44(4):1651-1664.
[12] Dong L, Hou X, Liu F, et al. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells[J]. Cell Biol Int, 2019, 43(5):553-564.
[13] Röhl M, Pasparakis M, Baudler S, et al. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance[J]. J Clin Invest, 2004, 113(3):474-481.
PDF(1456 KB)
